Moti Rosenstock

Discovery of Metabolomics Biomarkers for Early Detection of Nephrotoxicity

Kurt Boudonck, Matthew Mitchell, László Német et al. · Toxicologic Pathology · 2009 · 250 citations

Amino Acids, Metabolomic Profiling, Drug-induced Nephrotoxicity +17

Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study

Rohit Loomba, Eric Lawitz, Juan P. Frías et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 91 citations

Hepatology, Pharmacology, Pharmacological Issue +7

Effect of inhibition of glutathione synthesis on insulin action: in vivo and in vitro studies using buthionine sulfoximine

Mogher Khamaisi, Oren KAVEL, Moti Rosenstock et al. · Biochemical Journal · 2000 · 60 citations · Full text

Insulin Signaling, Oxidative Stress, Metabolic Syndrome +20

Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity

Sarah Pogue, Tetsuya Taura, Mingying Bi et al. · PLoS ONE · 2016 · 57 citations · Full text

Immunology, Immune Regulation, Immunoediting +19

Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-α in 3T3-L1 adipocytes

Moti Rosenstock, Andrew S. Greenberg, Assaf Rudich · Diabetologia · 2001 · 43 citations · Full text

Metabolic Syndrome, Distinct Long-term Regulation, Insulin Signaling +11